Literature DB >> 18428021

Mitochondrial involvement in psychiatric disorders.

Ling Shao1, Maureen V Martin, Stanley J Watson, Alan Schatzberg, Huda Akil, Richard M Myers, Edward G Jones, William E Bunney, Marquis P Vawter.   

Abstract

Recent findings of mitochondrial abnormalities in brains from subjects with neurological disorders have led to a renewed search for mitochondrial abnormalities in psychiatric disorders. A growing body of evidence suggests that there is mitochondrial dysfunction in schizophrenia, bipolar disorder, and major depressive disorder, including evidence from electron microscopy, imaging, gene expression, genotyping, and sequencing studies. Specific evidence of dysfunction such as increased common deletion and decreased gene expression in mitochondria in psychiatric illnesses suggests that direct examination of mitochondrial DNA from postmortem brain cells may provide further details of mitochondrial alterations in psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428021      PMCID: PMC3098560          DOI: 10.1080/07853890801923753

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  104 in total

Review 1.  Initiation and beyond: multiple functions of the human mitochondrial transcription machinery.

Authors:  Nicholas D Bonawitz; David A Clayton; Gerald S Shadel
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

2.  Temperature effects on pH of mitochondria isolated from carp red muscle.

Authors:  C D Moyes; L T Buck; P W Hochachka
Journal:  Am J Physiol       Date:  1988-04

3.  Patterns of maternal transmission in bipolar affective disorder.

Authors:  F J McMahon; O C Stine; D A Meyers; S G Simpson; J R DePaulo
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

4.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

Review 5.  Neuroimaging in bipolar disorder.

Authors:  S M Strakowski; M P DelBello; C Adler; D M Cecil; K W Sax
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

Review 6.  Mitochondria and degenerative disorders.

Authors:  M Orth; A H Schapira
Journal:  Am J Med Genet       Date:  2001

7.  Morbidity risk of schizophrenia to parents and siblings of schizophrenic patients.

Authors:  A Shimizu; M Kurachi; N Yamaguchi; H Torii; K Isaki
Journal:  Jpn J Psychiatry Neurol       Date:  1987-03

8.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia.

Authors:  Christopher Aston; Lixin Jiang; Boris P Sokolov
Journal:  J Neurosci Res       Date:  2004-09-15       Impact factor: 4.164

9.  Abnormal frontal lobe phosphorous metabolism in bipolar disorder.

Authors:  R F Deicken; G Fein; M W Weiner
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

Review 10.  Mitochondria and neurodegeneration.

Authors:  Lucia Petrozzi; Giulia Ricci; Noemi J Giglioli; Gabriele Siciliano; Michelangelo Mancuso
Journal:  Biosci Rep       Date:  2007-06       Impact factor: 3.840

View more
  100 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  MicroRNA-338 regulates the axonal expression of multiple nuclear-encoded mitochondrial mRNAs encoding subunits of the oxidative phosphorylation machinery.

Authors:  Armaz Aschrafi; Amar N Kar; Orlangie Natera-Naranjo; Margaret A MacGibeny; Anthony E Gioio; Barry B Kaplan
Journal:  Cell Mol Life Sci       Date:  2012-07-08       Impact factor: 9.261

3.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

Review 4.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 5.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 6.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 7.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

8.  Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia.

Authors:  Lilah Toker; Burak Ogan Mancarci; Shreejoy Tripathy; Paul Pavlidis
Journal:  Biol Psychiatry       Date:  2018-07-21       Impact factor: 13.382

9.  Stress and Psychiatric Disorders: The Role of Mitochondria.

Authors:  Teresa E Daniels; Elizabeth M Olsen; Audrey R Tyrka
Journal:  Annu Rev Clin Psychol       Date:  2020-02-24       Impact factor: 18.561

10.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.